Apuli Maricel sold BBIO
February 17, 2026 · Form 4 insider transaction
Apuli Maricel sold 510 shares of BridgeBio Pharma, Inc. at $74.31 per share, a transaction worth $37.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
510
Price
$74.31
Total value
$37.9K
InsiderApuli Maricel
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 17, 2026
Filing dateFebruary 18, 2026
Shares owned after123,945
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.